Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
פורמט: Article
שפה:English
יצא לאור: Taylor & Francis Group 2019-06-01
סדרה:CNS Oncology
נושאים:
גישה מקוונת:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

פריטים דומים